Results from experiments investigating Cu metabolism in ruminants indicate that Cu is involved in lipid metabolism. Copper supplementation ranging from 10 to 40 mg of Cu/kg of DM to high-concentrate finishing diets decreased subcutaneous adipose tissue deposition and decreased cholesterol concentrations but increased unsaturated fatty acid composition of LM. Serum norepinephrine tended to be greater in Cu-supplemented steers after a 24-h feed withdrawal and at 2 h postfeed consumption, potentially explaining the reduction in subcutaneous adipose tissue deposition. However, when exogenous norepinephrine was administrated, serum NEFA concentrations were less in Cu-supplemented steers, possibly due to the nonsupplemented control steers having a greater subcutaneous adipose tissue depth at slaughter relative to Cusupplemented steers. Furthermore, in vitro basal and epinephrine-stimulated lipolytic rates of subcutaneous adipose tissue were greater in Cu-supplemented steers relative to controls. These data indicate that that Cu may influence lipogenic or lipolytic function in subcutaneous adipose tissue. In an attempt to further investigate the effect of Cu on lipid metabolism, lipogenic, lipolytic, and homeostatic mechanisms related to Cu are currently being studied. Recent data indicate that genes involved in bovine liver Cu homeostasis are correlated with Cu transporter protein gene expression in the bovine liver. Therefore, the overall intent of this review is to discuss possible mechanisms whereby Cu may affect lipid metabolism in ruminants.
INTRODUCTION
Copper is an essential element required by cattle and other animals for numerous biochemical functions (Davis and Mertz, 1987) . Dietary Cu, when fed at physiological concentrations, has been shown to alter lipid metabolism in rats (Klevay, 1973; Petering et al., 1977) . Moreover, feeding pharmacological concentrations of Cu (i.e., 250 mg of Cu/kg of DM) decreased plasma and breast muscle cholesterol concentrations in poultry (Pesti and Bakalli, 1996) and increased unsaturated fatty acid and decreased SFA concentrations in 12th-rib subcutaneous adipose tissue of finishing pigs (Amer and Elliot, 1973a,b) .
Copper deficiency also was reported to alter lipid metabolism in nonruminants via increasing circulating concentrations of cholesterol. In rats, Cu deficiency increases activity of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme in cholesterol synthesis (Kim et al., 1992) . The mechanisms underlying Cu deficiency-induced hypercholesterolemia in nonruminants have been reviewed in detail (Lei, 1990; Kim et al., 1992) . However, few studies have been conducted examining the effect of Cu on lipid metabolism in ruminants. Available research in ruminants investigating the interaction of Cu and lipid metabolism indicates that dietary Cu at physiological concentrations does influence lipid metabolism. Therefore, the intent of this review is to discuss possible mechanisms whereby Cu may affect lipid metabolism in ruminants, thereby updating a previous review by Engle (2001) . steers were fed diets containing supplemental or no supplemental Cu for a total of 274 d. Copper-supplemented steers received 7.5 mg of Cu/kg of DM during the 29 d receiving phase and 5.0 mg of Cu/kg of DM during the growing and finishing phases. One-half of the steers in each Cu treatment were also supplemented with 5 mg of Mo, a known Cu antagonist, per kilogram of DM. Copper supplementation decreased 12th-rib subcutaneous adipose tissue depth, regardless of Mo supplementation, and tended to increase LM area. Liver Cu concentrations in biopsy samples obtained toward the end of the study were greater in Cu-supplemented steers, and Mo addition to the diet decreased liver Cu as expected. Plasma Cu concentrations were decreased only in steers supplemented with Mo and not receiving supplemental Cu.
A series of studies confirmed that dietary Cu affects 12th-rib subcutaneous adipose tissue depth and examined in more detail the effects of dietary Cu on lipid metabolism in feedlot cattle (Engle and Spears, 2000; Engle et al., 2000a,b) . In the first experiment, Angus and Angus × Hereford steers were fed a corn silagebased diet for 56 d followed by a high-concentrate cornbased finishing diet (i.e., approximately 87.0% cracked/ coarsely ground corn, 6.0% soybean meal, 5% cotton hulls, and 2% supplement) for 101 or 121 d. Copper was supplemented as CuSO 4 to provide 0, 20, or 40 mg of Cu/kg of DM of supplemental Cu. In addition, several other Cu sources (i.e., Cu citrate, Cu proteinate, and tribasic Cu chloride) were evaluated when supplemented at 20 mg of Cu/kg of DM. Copper supplementation to the diet at 20 mg of Cu/kg decreased 12th-rib subcutaneous adipose tissue depth without affecting marbling. Increasing the concentration of supplemental Cu from 20 to 40 mg of Cu/kg of DM did not further decrease 12th-rib subcutaneous adipose tissue depth. The different Cu sources did not differ in their ability to alter 12th-rib subcutaneous adipose tissue depth. Similar results were reported in goats. Copper supplementation at 100 mg of Cu/animal/d, or 200 mg of Cu/ animal/day to Boer × Spanish wether goats consuming a high concentrate finishing diet containing 13.8 mg of Cu/kg of DM linearly decreased 12th-rib subcutaneous adipose tissue depth relative to animal receiving no supplemental Cu (Solaiman et al., 2006) .
Cholesterol content of LM tended to be decreased by supplemental Cu and serum cholesterol concentrations were less in Cu-supplemented steers by d 84 of the finishing phase. Fatty acid composition of LM was also affected by Cu supplementation with PUFA (i.e., linoleic and linolenic acid) being greater in Cu-supplemented steers. The ratio of unsaturated fatty acids to SFA tended to be greater in Cu-supplemented steers as well. Liver and plasma Cu concentrations were less in control steers at the end of the study. However, liver and plasma Cu concentrations in control steers were greater than concentrations considered to be indicative of Cu deficiency.
In a second experiment, Cu was supplemented from CuSO 4 at 0, 10, or 20 mg of Cu/kg of DM during the finishing phase only (Engle and Spears, 2000) . Results of this study indicated that 10 mg of Cu/kg of DM was sufficient to decrease 12th-rib subcutaneous adipose tissue depth and alter muscle fatty acid profile. Similar to the results of Engle et al. (2000a,b) , the reduction in 12th-rib subcutaneous adipose tissue depth occurred without a decrease in marbling. The ratio of unsaturated fatty acids:SFA in LM and the percentage of total fatty acids as PUFA were greater in steers supplemented with Cu. The increase in muscle PUFA in steers supplemented with Cu may relate to Cu affecting ruminal biohydrogenation of dietary unsaturated fatty acids or the fatty acyl desaturase system. The decrease in 12th-rib subcutaneous adipose tissue depth in Cusupplemented steers may result from Cu altering catecholamine metabolism (Engle et al., 2000b) . Although not directly comparable, Cu supplemented (at 0, 100, or 200 mg per animal per day) to Boer × Spanish goats decreased C14:0 and C16:0 fatty acids in subcutaneous adipose tissue (Cummins et al., 2008) .
COPPER AND SUBCUTANEOUS ADIPOSE TISSUE METABOLISM
To further investigate the possible relationship of Cu and subcutaneous lipid metabolism, Engle et al. (2000b) utilized 48 Angus and Hereford × Angus steers to determine the effects of Cu on lipid and catecholamine metabolism. Treatments consisted of 0 (i.e., control, no supplemental Cu), 10, or 40 mg of supplemental Cu [from tribasic Cu chloride, Cu 2 (OH) 3 Cl]/kg of DM. Steers were fed a corn silage-soybean meal-based growing diet for 42 d and then gradually transitioned to a high-concentrate corn-based finishing diet (i.e., approximately 87.0% cracked-coarsely ground corn, 6.0% soybean meal, 5% cotton hulls, and 2% supplement). On d 70, indwelling jugular catheters were nonsurgically inserted into 5 steers per treatment. Blood samples were obtained from steers after a 24 h fast, 1 h after feeding, and pre-and postintravenous administration of norepinephrine, and subsequently analyzed for NEFA and catecholamine concentrations. Fasted serum norepinephrine and NEFA concentrations tended to be greater in Cu-supplemented steers. Postfeeding norepinephrine concentrations tended to be greater in Cu-supplemented steers. Nonesterified fatty acid concentrations were less in Cu-supplemented steers after norepinephrine administration. Furthermore, 12th-rib subcutaneous adipose tissue depth tended to be decreased in steers receiving supplemental Cu. These results agreed with earlier research indicating that dietary Cu decreases 12th-rib subcutaneous adipose tissue depth (Ward and Spears, 1997; Engle et al., 2000a) . The trend for greater fasted and fed plasma norepinephrine concentrations in Cusupplemented steers indicates that Cu supplementation may have increased lipolysis of adipose tissue, causEngle ing the observed reduction in 12th-rib subcutaneous adipose tissue depth. However, increases in circulating NEFA concentrations, as an indicator of increased lipolysis, were not detected in Cu-supplemented steers relative to the controls during the growing and finishing phases. If norepinephrine concentrations were slightly greater in Cu-supplemented steers, then lipolytic rates may have been slightly greater relative to controls; however, differences in lipolytic rates between treatments may have been too small to detect differences in serum NEFA concentrations.
In a similar experiment, Johnson and Engle (2003) utilized 48 individually fed Angus steers to examine the effects of Cu on in vitro lipolytic rates of subcutaneous adipose tissue. Treatments consisted of 1) control (no supplemental Cu), 2) 10 mg of Cu/kg of DM from CuSO 4 , and 3) 20 mg of Cu/kg of DM from CuSO 4 . Steers were fed a corn-alfalfa-based growing diet for 56 d and then transitioned to a high-concentrate finishing diet for 145 d. On d 74 of the finishing phase, subcutaneous adipose tissue biopsies were obtained from 3 steers/treatment to determine basal and stimulated lipolytic rates in vitro. Steers were then slaughtered after receiving the finishing diet for 145 d. Twelfth-rib subcutaneous adipose tissue depth tended to be less in Cusupplemented steers relative to controls. In vitro basal and epinephrine-stimulated lipolytic rates of subcutaneous adipose tissue were greater in Cu-supplemented steers relative to controls, indicating that Cu may play a role in lipid metabolism in subcutaneous adipose tissue. Basal lipolytic rates were approximately 23% greater in Cu-supplemented steers when compared with controls. However, the addition of epinephrine stimulated lipolysis by 55 and 50% in control and Cu-supplemented steers, respectively. Therefore, basal lipolysis seems to be enhanced by Cu supplementation but not epinephrine-stimulated lipolysis. These data indicate that Cu may have an influence on cellular mechanisms that control lipolysis and not catecholamine receptor numbers or sensitivity. These findings are in agreement with earlier research where Cu supplementation to Cudeficient sheep increased basal and stimulated lipolytic rates of subcutaneous adipose tissue (Sinnett-Smith and Woolliams, 1987) .
To further investigate the influence of Cu on lipid metabolism, Lee et al. (2002b) conducted an experiment to determine the effects of Cu supplementation on subcutaneous adipose tissue abundance of mRNA for acetyl CoA carboxylase (ACC), stearoyl CoA desaturase (SCD), uncoupling protein 2 (UCP2), and leptin in growing and finishing steers. 
COPPER AND CHOLESTEROL METABOLISM
As discussed in a previous review (Engle, 2001) , Kim et al. (1992) reported that Cu deficiency in rats causes hypercholesterolemia by increasing hepatic concentrations of the reduced form of glutathione (GSH) that subsequently increases the activity of 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in cholesterol synthesis. Increased concentrations of liver Cu may regulate cholesterol biosynthesis indirectly by decreasing reduced glutathione and increasing oxidized glutathione (Kim et al., 1992; Bakalli et al., 1995) . The decrease in cellular GSH may protect hepatic cells from the harmful free radical-forming toxic effects of increased Cu. As Cu enters the liver cells, it is rapidly complexed by GSH, and then it is transferred to metallothionein, the form in which it is stored (Freedman et al., 1989) . Increasing cellular oxidized glutathione concentrations was reported to decrease the activity of HMG-CoA reductase (Gilbert and Stewart, 1981; Roitelman and Schechter, 1984; Ziegler, 1985; Gilbert, 1990) . With a decrease in HMG-CoA reductase activity, carbon flux through the mevalonate pathway would be decreased, thus decreasing cholesterol synthesis.
The primary site of endogenous cholesterol synthesis in most mammals is the liver (Siperstein, 1970) . However, in ruminants the primary site of cholesterol synthesis is the small intestine and adipose tissue, with the liver producing a small proportion of the total endogenous cholesterol (Liepa et al., 1978) . The absorption of Cu from the intestinal lumen into the enterocyte is thought to require similar mechanisms as described for the liver. Therefore, it is hypothesized that supplemental Cu may decrease cholesterol synthesis in the liver and intestine (via similar mechanisms), resulting in an overall reduction in serum cholesterol in ruminants (Engle et al., 2000a) .
Serum total cholesterol concentrations and LM cholesterol concentrations (Engle and Spears, 2000; Engle et al., 2000a,b) have been decreased due to Cu supplementation in steers. However, lactating dairy cows appear to respond differently to dietary Cu . In that experiment, Holstein cows were assigned randomly to 1 of the following 3 treatments: 1) control (no supplemental Cu), 2) 10 mg of Cu/kg of DM from Cu sulfate (CuSO 4 ), or 3) 40 mg of Cu/kg of DM from CuSO 4 . Total serum cholesterol concentrations were greater in cows receiving supplemental Cu. Cows receiving 40 mg of Cu/kg of DM had greater serum cholesterol concentrations than cows receiving 10 mg of Cu. Dry matter intake, average daily milk production, and milk lipid, protein, and somatic cell numbers were similar across treatments. The effect of Cu supplementation on total serum cholesterol concentrations in that experiment was in contrast to results reported previously where Cu supplementation to finishing steers fed a high-concentrate diet at 10 or 20 mg of Cu/kg of DM decreased serum cholesterol concentration (Engle and Spears, 2000) . The discrepancy in the effect of dietary Cu on cholesterol metabolism between the 2 studies may be due to genetic or sex differences (Hardman et al., 2007) , differences in dietary components included in dairy and feedlot cattle rations, the presence or absence of trace mineral antagonists, and physiological status.
COPPER AND FATTY ACID METABOLISM
The fatty acyl desaturase systems seems to be a likely candidate as a potential mechanism for the observed increase in unsaturated fatty acids in LM of Cusupplemented steers. Feeding pharmacological concentrations of Cu increased estimated desaturase activity in pigs (Thompson et al., 1973) . Ho and Elliot (1974) reported that supplementation with 250 mg of Cu/kg of DM from CuSO 4 in pigs decreased proportions of stearic and palmitic acids with concomitant increases in the medium-chain myristic acid, as well as those of the major long-chain fatty acids in depot fat. Increases in the capacity of hepatic and adipose microsomes to desaturate 1-14 C-oleate and 1-14 C-palmitoyl-CoA relative to the controls receiving a basal diet that contained 15.0 mg of Cu/kg of DM were also observed. Therefore, dietary Cu seems to enhance the specific activity of desaturase enzymes, and this enhancement seems to contribute to the observed changes in fatty acid composition of the depot fat. In calves fed milk replacer with 1,000 mg of Cu/L, apparent delta-9-desaturase enzyme activity in calf liver and heart was greater than in control calves fed milk replacer containing 10 mg of Cu/L (Jenkins and Kramer, 1989) . Findings by Jenkins and Kramer (1989) were consistent with reports of increased dietary Cu promoting delta-9-desaturase activity in rat and swine liver (Cunnane, 1982) .
Another possible mechanism for the observed increase in unsaturated fatty acid composition in LM of Cusupplemented cattle may be due to the effect of Cu on ruminal biohydrogenation of unsaturated fatty acids. Biohydrogenation of C18:2 initiates with the isomerization of the cis-9, cis-12 molecule into cis-9 trans-11 C18:2 as the first intermediate (Kepler et al., 1966) . The subsequent step is a reduction of the cis-9 double bond, resulting in trans C18:1 as the second intermediate. This step involves a reductase using electron donors. The final step is another reduction, resulting in C18:0 (Hartfoot, 1981) . Copper may inhibit biohydrogenation of C18:2 by interfering with the formation of an electronegative center involved in the hydrogen transfer in the isomerization of C18:2 (Kepler et al., 1971) . Adding 20 or 40 mg of Cu/kg of DM to growing and finishing cattle diets increased PUFA proportions of total fat in LM (Engle et al., 2000a) . The C18:1 trans isomer, an intermediate of biohydrogenation (Kepler et al., 1966; Hartfoot, 1981) , was decreased in LM of Cu-supplemented steers, indicating an effect of Cu on biohydrogenation. Further research is needed to determine the effect of Cu on ruminal biohydrogenation of unsaturated fatty acids.
COPPER AND CATECHOLAMINE METABOLISM
Catecholamines are derived from tyrosine via the following pathway: tyrosine TH > dihyroxyphenylalanine (l-Dopa) DD > dopamine DBH > norepinephrine PNMT > epinephrine, where TH is tyrosine hydroxylase or 3-monoxygenase, DD is dopa decarboxylase, DBH is dopamine β hydroxylase, and PNMT is phenylethanolamine N-methyltransferase (Lefkowitz et al., 1996) . Research investigating the role of Cu in catecholamine synthesis has primarily compared Cu-deficient animals to Cu-adequate control animals. An early in vivo study showed that the conversion of dopamine to norepinephrine was impaired in Cu-deficient rats (Missala et al., 1967) . Later research indicated that Cu deficiency decreases the concentrations of norepinephrine in the brains of rats (Prohaska and Wells, 1974) and sheep (O'Dell et al., 1976 ). These findings demonstrate that the DBH-catalyzed step of dopamine to norepinephrine is the limiting step in Cu deficiency.
Dopamine-β-hydroxylase is a tetrameric glycoprotein that contains 8 Cu atoms when fully saturated (Ash et al., 1984) . Copper-deficient cattle fed a semi-purified diet deficient in Cu (i.e., 1.32 mg of Cu/kg of DM) for 355 d had less norepinephrine concentrations in adrenal tissue homogenates and tended to have less dopamine β hydroxylase enzyme activity relative to Cu-supplemented controls (Hesketh, 1981) . Prohaska et al. (1990) observed a 60% reduction in mice and rat plasma and heart norepinephrine concentrations with a concurrent increase of approximately 5 fold in dopamine concentrations relative to the controls. These findings are consistent with the concept that Cu deficiency depresses DBH activity. However, Cu-deficient mice and rats excreted twice as much dopamine and norepinephrine in the urine as the controls. Furthermore, Gross and Prohaska (1990) observed that urinary output of norepinephrine and dopamine was greater, whereas output of creatinine and epinephrine were not different between Cu-deficient and Cu-adequate mice. Calculated turnover rates of norepinephrine were greater in hearts from Cu-deficient mice than those from Cu-adequate mice. Gross and Prohaska (1990) suggested that the smaller norepinephrine pool observed in the organs of Cu-de-ficient mice may have resulted from reduced synthesis due to limiting dopamine β hydroxylase activity and to greater turnover.
Research investigating the effects of Cu supplementation above the requirement of an animal on catecholamine synthesis is limited. Lin et al. (1995) reported that Cu supplementation at 50 mg of Cu/kg of DM to genetically obese mice increased dopamine, norepinephrine, and epinephrine concentrations by 14, 50, and 31%, respectively, in the plasma and brain relative to control mice receiving 4 mg of Cu/kg of DM (Lin et al., 1995) . Furthermore, Cu supplementation to lean control mice tended to increase plasma dopamine, norepinephrine, and epinephrine concentrations by 3, 14, and 9%, respectively, relative to the nonsupplemented lean control mice. This was the first evidence indicating that Cu supplementation above the requirement of an animal may increase circulating concentrations of catecholamines. Furthermore, Cu supplementation to feedlot steers decreased 12th-rib subcutaneous adipose tissue depth and tended to increase circulating concentrations of norepinephrine relative to the unsupplemented controls (Engle et al., 2000b) .
CELLULAR COPPER HOMEOSTASIS AND LIPID METABOLISM
Copper homeostasis within the cell is mediated by the expression of Cu chaperone proteins, such as Cu transporter protein, ATPase Cu transporting α and β polypeptides A and B, and Cu chaperone for Cu-Zn superoxide dismutase, which help to regulate Cu uptake, export, and intracellular compartmentalization. Currently, data are available on the characterization and identification of mRNA associated with hepatic Cu metabolism and homeostasis in humans, mice, yeast (Lee et al., 2000 (Lee et al., , 2002a Lin et al., 2002) , and bovine (Han et al., 2009; So et al., 2010) .
Although data are not available describing the interaction of Cu trafficking and lipid metabolism, a better understanding of the molecular aspects of Cu metabolism and homeostasis in ruminants is necessary to determine how Cu influences lipid metabolism. Molecular aspects of Cu metabolism and homeostasis are well defined in some nonruminant species. However, it is difficult to compare mechanisms that regulate Cu homeostasis and lipid metabolism between ruminants and nonruminants because Cu metabolism and carbon and reducing equivalent sources involved in lipid metabolism differ between the species (Hanson and Ballard, 1967; O'Hea and Leveille, 1969; Ingle et al., 1972 Ingle et al., , 1973 .
SUMMARY AND CONCLUSIONS
The interactions between Cu and lipid metabolism are extremely complex. In nonruminants, it is clear that Cu plays a role in lipid metabolism; however, limited data indicate that dietary Cu at physiological concentrations can alter lipid metabolism in ruminants. Cattle and sheep are less tolerant of large dosages of Cu than most nonruminant species, which makes it difficult to investigate the impact of different doses of Cu on lipid metabolism due to the narrow range available for dose titration experiments. Therefore, a better understanding of Cu homeostasis in ruminants is warranted.
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